These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8466491)

  • 21. Saccharomyces cerevisiae elongation factor 2. Genetic cloning, characterization of expression, and G-domain modeling.
    Perentesis JP; Phan LD; Gleason WB; LaPorte DC; Livingston DM; Bodley JW
    J Biol Chem; 1992 Jan; 267(2):1190-7. PubMed ID: 1730643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the diphthamide-containing loop within eukaryotic elongation factor 2 in ADP-ribosylation by Pseudomonas aeruginosa exotoxin A.
    Zhang Y; Liu S; Lajoie G; Merrill AR
    Biochem J; 2008 Jul; 413(1):163-74. PubMed ID: 18373493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADP-ribosylatable content of elongation factor-2 changes during cell cycle of normal and cancerous human cells.
    Riis B; Rattan SI; Cavallius J; Clark BF
    Biochem Biophys Res Commun; 1989 Mar; 159(3):1141-6. PubMed ID: 2930555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha.
    Morimoto H; Bonavida B
    J Immunol; 1992 Sep; 149(6):2089-94. PubMed ID: 1517572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of the purified elongation factor 2 in the thermoacidophilic archaebacterium Sulfolobus solfataricus.
    Raimo G; Masullo M; Dello Russo A; Parente A; Gambacorta A; Bocchini V
    Ital J Biochem; 1993; 42(1):1-11. PubMed ID: 8468156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elongation factor 2 mutants deficient in diphthamide formation show temperature-sensitive cell growth.
    Kimata Y; Kohno K
    J Biol Chem; 1994 May; 269(18):13497-501. PubMed ID: 8175783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular ADP-ribosylation of elongation factor 2.
    Iglewski WJ
    Mol Cell Biochem; 1994 Sep; 138(1-2):131-3. PubMed ID: 7898455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleotide binding to elongation factor 2 inactivated by diphtheria toxin.
    Burns G; Abraham AK; Vedeler A
    FEBS Lett; 1986 Nov; 208(2):217-20. PubMed ID: 3780964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADP-ribosylated elongation factor 2 (ADP-ribosyl-EF-2) is unable to promote translocation within the ribosome.
    Davydova EK; Ovchinnikov LP
    FEBS Lett; 1990 Feb; 261(2):350-2. PubMed ID: 2311763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The ADP-ribosylation site and RNA-binding center are located in different regions of the elongation factor EF-2].
    Davydova EK
    Dokl Akad Nauk SSSR; 1986; 289(2):510-2. PubMed ID: 2427294
    [No Abstract]   [Full Text] [Related]  

  • 31. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
    Parikh SL; Schramm VL
    Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diphtheria toxin. Site and configuration of ADP-ribosylation of diphthamide in elongation factor 2.
    Oppenheimer NJ; Bodley JW
    J Biol Chem; 1981 Aug; 256(16):8579-81. PubMed ID: 6267047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the elongation factor 2 gene which confer resistance to diphtheria toxin and Pseudomonas exotoxin A. Genetic and biochemical analyses.
    Foley BT; Moehring JM; Moehring TJ
    J Biol Chem; 1995 Sep; 270(39):23218-25. PubMed ID: 7559470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced levels of ADP-ribosylatable elongation factor-2 in aged and SV40-transformed human cell cultures.
    Riis B; Rattan SI; Derventzi A; Clark BF
    FEBS Lett; 1990 Jun; 266(1-2):45-7. PubMed ID: 2163888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oxidative stress on in vivo ADP-ribosylation of eukaryotic elongation factor 2.
    Bektaş M; Akçakaya H; Aroymak A; Nurten R; Bermek E
    Int J Biochem Cell Biol; 2005 Jan; 37(1):91-9. PubMed ID: 15381153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The eukaryotic elongation factor EF-2 loses its nonspecific affinity for RNA as a result of ADP ribosylation].
    Bezlepkina TA; Davydova EK; Sitikov AS; Vertiev IuA; Ezepchuk IuV
    Dokl Akad Nauk SSSR; 1984; 278(3):751-4. PubMed ID: 6209075
    [No Abstract]   [Full Text] [Related]  

  • 37. A mutation in codon 717 of the CHO-K1 elongation factor 2 gene prevents the first step in the biosynthesis of diphthamide.
    Foley BT; Moehring JM; Moehring TJ
    Somat Cell Mol Genet; 1992 May; 18(3):227-31. PubMed ID: 1353910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
    Nygård O; Nilsson L
    Biochim Biophys Acta; 1985 Feb; 824(2):152-62. PubMed ID: 3970930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment.
    Ergen K; Bektaş M; Gökçe S; Nurten R
    Biocell; 2007; 31(1):61-6. PubMed ID: 17665640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttranslational modification of elongation factor 2 in diphtheria-toxin-resistant mutants of CHO-K1 cells.
    Moehring JM; Moehring TJ; Danley DE
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):1010-4. PubMed ID: 6928655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.